166
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Issues Affecting Medication-Taking Behavior of People with Type 2 Diabetes in Indonesia: A Qualitative Study

ORCID Icon, ORCID Icon, &
Pages 989-998 | Published online: 17 May 2021

References

  • International Diabetes Federation. IDF diabetes atlas - Eighth edition 2017. International Diabetes Federation; 2017: Available from:https://diabetesatlas.org/upload/resources/previous/files/8/IDF_DA_8e-EN-final.pdf . Accessed January 3, 2019.
  • Soetedjo NNM, McAllister SM, Ugarte-Gil C, et al. Disease characteristics and treatment of patients with diabetes mellitus attending government health services in Indonesia, Peru, Romania and South Africa. Trop Med Int Health. 2018;23(10):1118–1128. doi:10.1111/tmi.13137
  • Agustina R, Dartanto T, Sitompul R, et al. Universal health coverage in Indonesia: concept, progress, and challenges. Lancet. 2019;393(10166):75–102. doi:10.1016/S0140-6736(18)31647-7
  • Egede LE, Gebregziabher M, Echols C, Lynch CP. Longitudinal effects of medication nonadherence on glycemic control. Ann Pharmacother. 2014;48(5):562–570. doi:10.1177/1060028014526362
  • Huang Y-M, Pecanac KE, Shiyanbola OO. “Why am i not taking medications?” Barriers and facilitators of diabetes medication adherence across different health literacy levels. Qual Health Res. 2020;30(14):2331–2342. doi:10.1177/1049732320945296
  • Shiyanbola OO, Brown CM, Ward EC. “I did not want to take that medicine”: African-Americans’ reasons for diabetes medication nonadherence and perceived solutions for enhancing adherence. Patient Prefer Adherence. 2018;12:409–421. doi:10.2147/PPA.S152146
  • Sapkota S, Brien JAE, Aslani P. Nepalese patients’ perceptions of treatment modalities for type 2 diabetes. Patient Prefer Adherence. 2016;10:1777–1786. doi:10.2147/PPA.S113467
  • Kumar K, Greenfield S, Raza K, Gill P, Stack R. Understanding adherence-related beliefs about medicine amongst patients of South Asian origin with diabetes and cardiovascular disease patients: a qualitative synthesis. BMC Endocr Disord. 2016;16(1). doi:10.1186/s12902-016-0103-0
  • Alqarni AM, Alrahbeni T, Qarni AA, Qarni HMA. Adherence to diabetes medication among diabetic patients in the Bisha governorate of Saudi Arabia - a cross-sectional survey. Patient Prefer Adherence. 2018;13:63–71. doi:10.2147/PPA.S176355
  • Aminde LN, Tindong M, Ngwasiri CA, et al. Adherence to antidiabetic medication and factors associated with non-adherence among patients with type-2 diabetes mellitus in two regional hospitals in Cameroon. BMC Endocr Disord. 2019;19(1):35. doi:10.1186/s12902-019-0360-9
  • Kardas P, Lewek P, Matyjaszczyk M. Determinants of patient adherence: a review of systematic reviews. Front Pharmacol. 2013;4:91. doi:10.3389/fphar.2013.00091
  • Sohal T, Sohal P, King-Shier KM, Khan NA. Barriers and facilitators for type-2 diabetes management in South Asians: a Systematic Review. PLoS One. 2015;10(9):e0136202. doi:10.1371/journal.pone.0136202
  • Krass I, Schieback P, Dhippayom T. Adherence to diabetes medication: a systematic review. Diabet Med. 2015;32(6):725–737. doi:10.1111/dme.12651
  • McSharry J, McGowan L, Farmer AJ, French DP. Perceptions and experiences of taking oral medications for the treatment of type 2 diabetes mellitus: a systematic review and meta-synthesis of qualitative studies. Diabet Med. 2016;33(10):1330–1338. doi:10.1111/dme.13152
  • Gellad WF, Grenard JL, Marcum ZA. A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity. Am J Geriatr Pharmacother. 2011;9(1):11–23. doi:10.1016/j.amjopharm.2011.02.004
  • World Health Organization. Adherence to Long Term Therapies, Evidence for Action. Geneva: World Health Organization; 2003.
  • Horne R, Cooper V, Wileman V, Chan A. Supporting adherence to medicines for long-term conditions: a perceptions and practicalities approach based on an extended common-sense model. Eur Psychol. 2019;24(1):82–96. doi:10.1027/1016-9040/a000353
  • Chan AHY, Cooper V, Lycett H, Horne R. Practical barriers to medication adherence: what do current self- or observer-reported instruments assess? Front Pharmacol. 2020;11:572. doi:10.3389/fphar.2020.00572
  • Clifford S, Barber N, Horne R. Understanding different beliefs held by adherers, unintentional nonadherers, and intentional nonadherers: application of the necessity-concerns framework. J Psychosom Res. 2008;64(1):41–46. doi:10.1016/j.jpsychores.2007.05.004
  • Widayanti AW, Norris P, Heydon S, Green JA. Medicine taking behaviours of people with type 2 diabetes in Indonesia: a qualitative study. Int J Clin Pharm Net. 2020;42(1):31–39. doi:10.1007/s11096-019-00933-0
  • Widayanti AW, Heydon S, Norris P, Green JA. Lay perceptions and illness experiences of people with type 2 diabetes in Indonesia: a qualitative study. Health Psychol Behav Med. 2020;8(1):1–15. doi:10.1080/21642850.2019.1699101
  • Alfian SD, Sukandar H, Arisanti N, Abdulah R. Complementary and alternative medicine use decreases adherence to prescribed medication in diabetes patients. Ann Trop Med Public Health. 2016;9(3):174–179. doi:10.4103/1755-6783.179108
  • Creswell JW, Creswell JD. Research Design: Qualitative, Quantitative, and Mixed Methods Approaches. Sage publications; 2017.
  • Barbour RS. Focus Groups. In: Bourgeault I, Dingwall R, Rd V, editors. The SAGE Handbook of Qualitative Methods in Health Research. London: SAGE Publications. SAGE Publications; 2010:327–334.
  • Statistics of Indonesia. Infografis hasil sensus penduduk Indonesia 2020 [the results of Indonesia 2020 census]; 2021. Available from: https://www.bps.go.id/website/images/Hasil-SP2020-ind.jpg. Accessed March 5, 2021.
  • Al-Qazaz HK, Sulaiman SA, Hassali MA, et al. Diabetes knowledge, medication adherence and glycemic control among patients with type 2 diabetes. Int J Clin Pharm Net. 2011;33(6):1028–1035. doi:10.1007/s11096-011-9582-2
  • Mohammed MA, Moles RJ, Chen TF. Medication-related burden and patients’ lived experience with medicine: a systematic review and metasynthesis of qualitative studies. BMJ Open. 2016;6(2):e010035. doi:10.1136/bmjopen-2015-010035
  • Elo S, Kyngäs H. The qualitative content analysis process. J Adv Nurs. 2008;62(1):107–115. doi:10.1111/j.1365-2648.2007.04569.x
  • OpenCode 4.0 [computer program]. Sweden: University of Umeå; 2013.
  • Saunders B, Sim J, Kingstone T, et al. Saturation in qualitative research: exploring its conceptualization and operationalization. Qual Quant. 2018;52(4):1893–1907. doi:10.1007/s11135-017-0574-8
  • World Medical Association. World medical association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191–2194. doi:10.1001/jama.2013.281053
  • Frandsen KB, Kristensen JS. Diet and lifestyle in type 2 diabetes: the patient’s perspective. Pract Diabetes Int. 2002;19(3):77–80. doi:10.1002/pdi.327
  • Ruszala V. Question from practice: diabetes - missing meals and doses. Pharm J. 2013;291:57.
  • Carlson O, Martin B, Stote KS, et al. Impact of reduced meal frequency without caloric restriction on glucose regulation in healthy, normal-weight middle-aged men and women. Metabolism. 2007;56(12):1729–1734. doi:10.1016/j.metabol.2007.07.018
  • Aljuraiban GS, Chan Q, Oude Griep LM, et al. The impact of eating frequency and time of intake on nutrient quality and body mass index: the INTERMAP Study, a population-based Study. J Acad Nutr Diet. 2015;115(4):528–536.e521. doi:10.1016/j.jand.2014.11.017
  • Hashimoto K, Urata K, Yoshida A, et al. The relationship between patients’ perception of type 2 diabetes and medication adherence: a cross-sectional study in Japan. J Pharm Health Care Sci. 2019;5(1):2. doi:10.1186/s40780-019-0132-8
  • Polonsky WH, Henry RR. Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors. Patient Prefer Adherence. 2016;10:1299–1307. doi:10.2147/PPA.S106821
  • Roborel de Climens A, Pain E, Boss A, Shaunik A. Understanding reasons for treatment discontinuation, attitudes and education needs among people who discontinue type 2 diabetes treatment: results from an online patient survey in the USA and UK. Diabetes Ther. 2020;11(8):1873–1881. doi:10.1007/s13300-020-00843-9
  • Guerci B, Chanan N, Kaur S, Jasso-Mosqueda JG, Lew E. Lack of treatment persistence and treatment nonadherence as barriers to glycaemic control in patients with type 2 diabetes. Diabetes Ther. 2019;10(2):437–449. doi:10.1007/s13300-019-0590-x
  • Indonesia Ministry of Health. Formularium Nasional (National Formulary). Jakarta: Indonesia Ministry of Health; 2019.
  • Misnikova I, Dreval A, Gubkina V, Rusanova E. The risks of repeated use of insulin pen needles in patients with diabetes mellitus. J Diabetol. 2011;2(1):2.
  • Blanco M, Hernández MT, Strauss KW, Amaya M. Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes. Diabetes Metab. 2013;39(5):445–453. doi:10.1016/j.diabet.2013.05.006
  • Puder JJ, Atar M, Muller B, Pavan M, Keller U. Using insulin pen needles up to five times does not affect needle tip shape nor increase pain intensity. Diabetes Res Clin Pract. 2005;67(2):119–123. doi:10.1016/j.diabres.2004.06.001
  • U.S. Food and Drug Administration. Information regarding insulin storage and switching between products in an emergency; 2017; Available from: https://www.fda.gov/drugs/emergency-preparedness-drugs/information-regarding-insulin-storage-and-switching-between-products-emergency. Accessed August 20, 2020.
  • Vimalavathini R, Gitanjali B. Effect of temperature on the potency & pharmacological action of insulin. Indian J Med Res. 2009;130(2):166–169.
  • Newman TV, San-Juan-Rodriguez A, Parekh N, et al. Impact of community pharmacist-led interventions in chronic disease management on clinical, utilization, and economic outcomes: an umbrella review. Res Social Adm Pharm. 2020;16(9):1155–1165. doi:10.1016/j.sapharm.2019.12.016
  • Snyder JM, Ahmed-Sarwar N, Gardiner C, Burke ES. Community pharmacist collaboration with a primary care clinic to improve diabetes care. J Am Pharm Assoc. 2020;60(3):S84–S90. doi:10.1016/j.japh.2020.02.005
  • Wibowo Y, Parsons R, Sunderland B, Hughes J. An evaluation of community pharmacy-based services for type 2 diabetes in an Indonesian setting: patient survey. PeerJ. 2015;3:e1449. doi:10.7717/peerj.1449
  • Indonesia Ministry of Health. Peraturan Menteri Kesehatan No 73 tahun 2016 tentang Standard Pelayanan Kefarmasian di Apotek [Ministry of health regulation No. 73 year 2016 about standar for pharmaceutical care in community pharmacies]. Indonesia Ministry of Health; 2016.
  • Wibowo Y, Parsons R, Sunderland B, Hughes J. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey. Int J Clin Pharm Net. 2015;37(5):873–882. doi:10.1007/s11096-015-0135-y
  • Habte BM, Kebede T, Fenta TG, Boon H. Ethiopian patients’ perceptions of anti-diabetic medications: implications for diabetes education. J Pharm Policy Pract. 2017;10(1):14. doi:10.1186/s40545-017-0101-2
  • Williams PA, Prabandari YS, Burfeind C, Lefebvre RC, LaBresh KA. Impact of a pilot intervention to increase physician–patient communication about stroke risk in Indonesia. Health Commun. 2016;31(12):1573–1578. doi:10.1080/10410236.2015.1082456
  • Viswanathan M, Kahwati LC, Golin CE, et al. Medication therapy management interventions in outpatient settings: a systematic review and meta-analysis. JAMA Intern Med. 2015;175(1):76–87. doi:10.1001/jamainternmed.2014.5841
  • Dodson SE, Ruisinger JF, Howard PA, Hare SE, Barnes BJ. Community pharmacy-based medication therapy management services: financial impact for patients. Pharm Pract (Granada). 2012;10(3):119–124. doi:10.4321/S1886-36552012000300001